✦ LIBER ✦

The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma

✍ Scribed by Jonathan D. Tward; Merideth M. M. Wendland; Dennis C. Shrieve; Aniko Szabo; David K. Gaffney

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 98 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21971

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The risk of secondary malignancies over

The risk of secondary malignancies over 30 years after the treatment of non-hodgkin lymphoma

✍ Linda Morris Brown; Regan A. Howard; Lois B. Travis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

The Risk of Secondary Malignancies Over 30 Years After the Treatment of Non-Hodgkin Lymphoma T ward et al. 1 reported a significantly elevated risk of mesothe- lioma in a population-based study of survivors of non-Hodgkin lymphoma who were treated with radiation. Although the authors were not aware

Treatment of aggressive non-hodgkin's ly

Treatment of aggressive non-hodgkin's lymphomas: Lessons from the past 10 years

✍ Richard I. Fisher 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

Therapy for aggressive non-Hodgkin's lymphomas has undergone significant evolution in the last 25 years. First generation combination chemotherapy studies produced complete remissions (CRs) of 45-53%, with 30-37% long term survivors. New treatment programs aimed at increasing CR rates were then deve

Non-Hodgkin's lymphoma of the head and n

Non-Hodgkin's lymphoma of the head and neck: A 30-year experience at the university of Florida

✍ Rakesh M. Nathu; Nancy Price Mendenhall; Nidal M. Almasri; James W. Lynch 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

Background. Outcome in previously untreated patients with non-Hodgkin's lymphoma of the head and neck needed to be assessed. Methods. A retrospective review was performed of 79 patients with stage I or II non-Hodgkin's lymphoma of the head and neck treated between 1964 and 1994 with radiotherapy (R

Prognosis and treatment after relapse of

Prognosis and treatment after relapse of acute lymphoblastic leukemia and non-Hodgkin's lymphoma: 1985: A report from the childrens cancer study group

✍ W. Archie Bleyer; Harland Sather; G. Denman Hammond 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB 👁 3 views

Detection of soluble interleukin-2 recep

Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma.Identification of a subset at high risk of treatment failure

✍ Roberto Stasi; Pier Luigi Zinzani; Piero Galieni; Vito Michele Lauta; Eugenio Da 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 875 KB